Spectrophotometric methods for the determination of omeprazole in bulk form and pharmaceutical formulations

Four simple and sensitive methods for the assay of omeprazole (OMZ) were developed. These methods are based on the formation of colored species by treating OMZ with 3-methyl-2-benzothiazolinone hydrazone (MBTH) following oxidation with ferric chloride (method A) or m-aminophenol following oxidation with chloramine-T (CAT) (method B) or Folin-Ciocalteau reagent (FC) (method D), or by oxidizing OMZ with excess N-bromosuccinimide (NBS) and determining the consumed NBS with a decrease in color intensity of Celestine blue (CB) (method C). All variables have been optimized. Regression analysis of Beer's plots showed good correlation in the concentration range of 1.0-10, 2.0-32, 0.4-2.4 and 0.8-10 mug ml(-1) for methods A, B, C and D, respectively. No interference was observed for formulation additives and the validity of each method was tested by analysing capsules containing OMZ. Recoveries were 98.7-100.1%.     

Spectrophotometric Methods for the Determination of Nelfinavir Mesylate

Three visual spectrophotometric methods are described for the assaying of nelfinavir mesylate (NEL) in either bulk form or dosage forms. Methods A-C are based on the oxidation of NEL with an excess of oxidant (N-bromosuccinimide (NBS) in methods A&B or chloramine-T (CAT) in method C) in acidic medium. The unreacted oxidant is then estimated colorimetrically using an oxidisable dye (Celistine blue (CB) in method A or Gallocyanine (GC) in method C) or p-N-methyl aminophenol sulphate (PMAP)-sulphanilamide (SA) reagent (in method B). These methods obey Beer's law and give reproducible results. Recoveries range from 99.3–100.5%.     

Spectrophotometric methods for the determination of nifurtimox in bulk form and pharmaceutical formulations

Three simple and sensitive methods for the assay of Nifurtimox (NIF) which is an active antitrypanocide were developed. These methods are based on the formation of coloured species by treating either its reduction product with 3-methyl-2-benzothiazolinone hydrazone (MBTH) in the presence of ferric chloride (method A) or its hydrolysis product with 2-thiobarbituric acid (TBA) (method B) or by oxidizing it with excess N-bromosuccinamide (NBS) and determining the consumed NBS using p-N-methylaminophenol sulphate (metol)-isonicotinic acid hydrazide (INH) (method C). All variables have been optimized and the reaction mechanisms presented. Regression analysis of Beer's plot showed good correlation in the concentration range of 2.5-10, 2.5-30 and 1.25-7.5 microg/ml for methods A, B and C, respectively. No interference was observed from the additives and the validity of the methods was tested by analysing the tablets. Recoveries were 99.2-100.9%.     

Spectrophotometric Estimation of Nimesulide and its Formulations

 Four simple and sensitive visible spectrophotometric methods (A–D) have been described for the assay of nimesulide (NMD) either in pure form or in pharmaceutical formulations. Methods A and B are based on the oxidative coupling between the reduced product of NMD (RNMD) and p-N,N-dimethyl phenylenediamine dihydrochloride (DMPD) in presence of chloramine – T (CAT) or 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) in presence of ferric chloride (Fe III) to form coloured products with λ_max at 540 nm and 600 nm respectively. Method C is based on the diazotization of RNMD with excess nitrous acid (HNO₂) and estimating the consumed HNO₂ with cresyl fast violet acetate (CFVA). Method D is based on the formation of the coloured charge-transfer complex, when RNMD is treated with metol (p-methyl aminophenol sulphate, PMAP) in presence of potassium dichromate. All variables have been optimized and the reaction sequence is presented. The concentration measurements are reproducible within a relative standard deviation of 1.0%. Recoveries are 98.6–100.2%. Received February 5, 1998. Revision February 20, 1999.     

Spectrophotometric methods for the determination of prazosin hydrochloride in tablets

Four simple and sensitive methods for the assay of prazosin hydrochloride (PRH) are developed. These methods are based on the formation of coloured species by treating it either with excess N-bromosuccinimide (NBS) and determining the unconsumed NBS with p-N-methyl aminophenol sulphate (metol)-sulphanilamide (SA) reagent (method A, lambda(max) 520 nm): with 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) in the presence of eerie ammonium sulphate (CAS) (method B, lambda(max) 620 nm) or with acidic dyes such as orange-II (O-II) (method C, lambda(max) 490 nm) and alizarin violet 3B (AV-3B) (method D, lambda(max) 570 nm) under the specified experimental conditions. Regression analysis of Beer's law plot showed good correlation in the concentration range of 1.0-10.0, 2.5-25.0, 1.0-17.5 and 2.5-30.0 mug ml for methods A, B, C and D respectively.     

Four spectrophotometric methods for determination of nitrofurazone in pharmaceutical formulations

Four simple and sensitive visible spectrophotometric methods (A-D) for the determination of nitrofurazone in bulk samples and pharmaceutical formulations are described. They are based on the formation of colored species by treating either its reduction product with 3-methylbenzothiazolin-2-one hydrazone in the presence of ferric chloride (method A: _max 600 nm) or its hydrolysis product with thiobarbituric acid (method B: _max 520 nm, 440 nm) or barbituric acid (method C: _max 400 nm) or by oxidizing it with excess N-bromosuccinimide and determining the consumed NBS using metol-isonicotinic acid hydrazide (method D: _max 620 nm).     

Three simple spectrophotometric methods for the determination of sulphinpyrazone

Three simple and sensitive spectrophotometric methods for the determination of sulphinpyrazone (SP) in bulk samples and pharmaceutical formulations are described. They are based on the oxidation of sulphinpyrazone with excess N-bromosuccinimide (NBS) and determination of the unconsumed NBS with metol-isonicotinic acid hydrazide (method A, lambda(max): 620 nm); by the reduction of Folin-Ciocalteu reagent (method B, lambda(max) 770 nm); or by the formation of a chloroform-soluble, coloured ion-association complex between the drug and Methylene Violet (MV) at pH 7.0 (method C, lambda(max) 545 nm).     

Spectrophotometric determination of astemizole

Four simple and sensitive spectrophotometric methods for the determination of astemizole (AZ) in pure samples and pharmaceutical formulations are described. They are based on the oxidation of astemizole with excess N-bormosuccinimide (NBS) and determination of the unconsumed NBS with, metol-sulphanilamide (method A, lambda(max): 520 nm) or celestine blue (method B, lambda(max): 540 nm); or by the reduction of Folin-ciocalteu reagent (method C, lambda(max): 720 nm); or by the formation of a chloroform-soluble, coloured ion-association complex between the drug and azocarmine G (AG) at pH 1.5 (method D, lambda(max); 540 nm). The results obtained are reproducible with a coefficient of variation of less than 1.0%.     

Application of sodium metaperiodate for the determination of ribavirin in pharmaceutical formulations

Three simple and sensitive visible spectrophotometric methods (A-C) have been described for the assay of ribavirin either in pure form or in pharmaceutical formulations. They are based on the oxidation of ribavirin with excess sodium metaperiodate and estimating either the products formed (dialdehyde with MBTH, method A; iodate with metol-sulphanilamide, in the presence of Mo(VI) and iodide, method B) or the amount of periodate consumed (celestine blue in the presence of telurium (IV), method C). All of the variables have been optimized and the reaction mechanisms presented. The concentration measurements are reproducible within a R.S.D. of 1.0%. Recoveries are 99.2-101.2%.     

Spectrophotometric estimation of ketotifen fumarate in pharmaceutical formulations

Four simple and sensitive spectrophotometric methods (A–D) for the determination of Ketotifen fumarate in bulk samples and pharmaceutical formulations are described. They are based on the formation of coloured species by the coupling of the diazotised sulphanilamide with the drug (method A, _max 520 nm) or by oxidizing it with excessN-bromo-succinimide and determining the consumed NBS with decrease in colour intensity of celestine blue (method B: _max 540 nm) or by the reduction of Folin-Ciocalteau reagent (method C: _max 720 nm) or by the formation of a chloroform-soluble, coloured ionassociation complex between the drug and Azocarmine G at pH 1.5 (method D: _max 540 nm). Regression analysis of Beer-Lambert plots showed good correlations in the concentration ranges 1–10, 2–12, 4–28 and 2.5–25 g/ml for methods A–D, respectively. The validity of the proposed methods was tested by analysing pharmaceutical formulations containing KTF: the relative standard deviations were within ±1.0%. Recoveries were 98.9–100.2%.     

Investigations of benzimida zole derivatives

The reaction of 2-aminomethyl- and 2-aminomethyl-1-methylbenzimidazoles with nitrous acid was investigated. The reaction proceeds with nitrogen evolution with excess hydrochloric or hydrobromic acids to form 2-chloro- and 2-bromomethylbenzimidazoles, while 2-benzimidazolylmethylnitrolic acids and other products are obtained with excess nitrous acid.For Communication XXII, see [1].Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 10, pp. 1393–1396, October, 1970.     

Electron transfer reactions of V(IV) with Cl(I), Br(I) and I(I). A kinetic study

A kinetic study on the oxidation of V(IV) by chloramine-T (CAT) at pH 6.85 by N-bromo succinimide (NBS) in aqueous acetic acid–perchloric acid media and by N-iodo succinimide (NIS) in aqueous perchloric acid medium has been carried out. In all the systems studied the order with respect to the oxidant is unity. NBS and CAT oxidation reactions exhibited Michaelis–Menten type kinetics, and the NIS study indicated unit dependence on [substrate]. Independence on acidity has been observed in the case of CAT and NBS reactions, but NIS reactions exhibited inverse unit dependence on [acid]. Novel solvent influences have been noticed in the case of CAT reactions, but with NIS and NBS reactions retardation in the rate has been observed with an increase in the percentage of acetic acid. Plausible mechanisms consistent with the results have been postulated, and suitable rate laws in consonance with the postulated mechanisms have been derived.     

Influence of the built-in pyridinium salt on asymmetric epoxidation of substituted chromenes catalysed by chiral (pyrrolidine salen)Mn(III) complexes

Chiral (pyrrolidine salen)Mn(III) complexes 1 with an N-benzoyl group and 2 with an N-isonicotinoyl group as well as the corresponding N-methyl (3) and N-benzyl (4) pyridinium salts of 2 were synthesized. The catalytic properties of 1–4 and 2 with excess CH₃I were explored to figure out the influence of the internal pyridinium salt in the catalyst on asymmetric epoxidation of substituted chromenes with NaClO/PPNO as an oxidant system in the aqueous/organic biphasic medium. The (pyrrolidine salen)Mn(III) complexes with an internal pyridinium salt, either formed in situ or isolated, displayed higher activities than analogous complexes 1, 2 and Jacobsen's catalyst in the aforementioned reaction, with comparable high yields and ee values. The acceleration of the reaction rate is attributed to the phase transfer capability of the built-in pyridinium salt of the (salen)Mn(III) catalyst. The effect of the internal pyridinium salt on the epoxidation of substituted chromenes is similar to that of the external pyridinium salts and ammonium halides.     

Constructions of a set of novel hydrogen-bonded supramolecules from reactions of cobalt(II) salt with bis(3,5-dimethylpyrazolyl)methane and different carboxylic acids

Reactions of CoX₂·6H₂O (X = Cl⁻, ClO₄⁻) with bis(3,5-dimethylpyrazolyl)methane (dmpzm) and formic acid, acetic acid, benzoic acid, salicylic acid, maleic acid, or fumaric acid under the presence of KOH solution produced a new family of Co(II)/dmpzm complexes, [Co(dmpzm)₂L]X·nH₂O (1: L = O₂CH, X = Cl, n = 2; 2: L = OAc, X = Cl, n = 3; 3: L = benzoate, X = ClO₄, n = 1/3; 4: L = salicylate, X = ClO₄, n = 1/3) and [Co₂(dmpzm)₄L](ClO₄)₂·nSolv (5: L = maleate, n = 3, Solv = H₂O; 6: L = fumarate, n = 2, Solv = MeOH). These compounds were structurally characterized by elemental analysis, IR spectroscopy, and single-crystal X-ray diffraction. Compounds 1–4 are mononuclear while 5–6 are binuclear. Each cobalt atom of 1–6 is hexacoordinate, with a distorted octahedral CoN₄O₂ coordination geometry incorporating two N,N′-bidentate dmpzm ligands and one O,O′-bidentate carboxylate ligand. There are rich intra- and intermolecular hydrogen bonds in the crystals of 1–6, thereby forming either 2D hydrogen-bonded networks (1 and 2) or 3D hydrogen-bonded networks (3–6). In addition, the thermal behaviors of 1–6 were also investigated.     

Molecular structure and vibrational spectra of N-mesylhydroxylamin and N-mesyl-O-methylhydroxylamin by density functional theory and ab initio Hartree–Fock calculations

The molecular geometry and vibrational frequencies of N-mesylhydroxylamin (N-MHN) and N-mesyl-O-methylhydroxylamin (N-MMHN) in the ground state have been calculated using the Hartree–Fock and density functional method (B3LYP) with 6-31G(d) basis set. The optimized geometric band lengths and bond angles obtained by using HF and DFT (B3LYP) show the best agreement with the experimental data. Comparison of the observed fundamental vibrational frequencies of N-MHN and N-MMHN and calculated results by density functional B3LYP and Hartree–Fock methods indicate that B3LYP is superior to the scaled Hartree–Fock approach for molecular vibrational problems.     

Microstructure determination of N-vinyl-2-pyrrolidone/butyl acrylate copolymers by NMR spectroscopy

The copolymer composition of N-vinyl-2-pyrrolidone/butyl acrylate (V/B) copolymers was determined from the quantitative ¹³C{¹H} NMR spectra. The monomer reactivity ratios for N-vinyl-2-pyrrolidone (V) and butyl acrylate (B) were found to be r_V=0.11±0.07, r_B=0.54±0.19, using the Kelen–Tudos and non-linear least-square error-in-variable (EVM) methods. The ¹³C{¹H} and ¹H NMR spectra of these copolymers are overlapping and complex. The complete spectral assignment of the carbon and proton NMR spectra were done by employing distortionless enhancement by polarization transfer (DEPT) and two-dimensional (2D) ¹³C–¹H heteronuclear single quantum correlation spectroscopy experiments. The 2D total correlation spectroscopy (TOCSY) (¹H–¹H homonuclear TOCSY) NMR spectrum was used to ascertain the various geminal and vicinal couplings in the copolymer.     

Molecular and crystal structures of N,N′-propylene- and N,N′-phenylene-diylbis [3-(1-aminoethyl)-6-methyl-2H-pyran-2,4(3H)-dione]

Two macrocyclic ligands, N,N′-propylene-diylbis[3-(1-aminoethyl)-6-methyl-2H-pyran-2,4(3H)-dione] I and N,N′-phenylene-diylbis[3-(1-aminoethyl)-6-methyl-2H-pyran-2,4(3H)-dione] II, have been prepared by the condensation of dehydroacetic acid (3-acetyl-4-hydroxy-6-methyl-2H-pyran-2-one) with 1,2-phenylenediamine and 1,3-propylenediamine. They have been characterized by means of elemental analysis, IR spectroscopy as well as by X-ray crystallography. The molecular structures of the compounds I and II can be described as consisting of two β-enaminone-2-pyrone rings interlaced with either alkyl chain in I or phenyl ring in II. The X-ray studies confirmed the existence of strong N–HO intramolecular hydrogen bonds in both structures. Their lengths are in accordance to lengths of RAHB intramolecular hydrogen bonds in 1,3-diketones, aryl-hydrazones, β-enaminones and related heterodienes (2.5–2.6 Å) [P. Gilli, V. Bertolasi, V. Ferretti and G. Gilli, J. Am. Chem. Soc., 122 (2000) 10405].     

Liquid phase bromination of aromatics over zeolite H-beta catalyst

The liquid phase bromination of chlorobenzene, toluene and xylenes (o-, m-, p-) is catalyzed using zeolite as catalyst and N-bromosuccinimide (NBS) as the brominating agent. In addition, the bromination of toluene has been investigated over various zeolites using both NBS and liquid Br₂ as brominating agents. A comparison under similar reaction conditions with H₂SO₄, in the absence of catalyst and FeCl₃ (in the case of toluene) is also investigated for each reaction. Zeolite H-beta is found to be selective compared to the conventional catalysts and other zeolites in the bromination of chlorobenzene and toluene whereas selectivity for 4-bromo-o-xylene (4-BOX/3-BOX) over H-beta and H₂SO₄ was found nearly comparable in the bromination of o-xylene. In the bromination of toluene, acidic H-beta favours the formation of nuclear products whereas in the absence of any catalyst, in the presence of weakly acidic H–Y and potassium exchanged zeolites K-beta and K–L, the concentration of side-chain product, œ-bromotoluene, is enhanced. The conversion of NBS, rate of NBS conversion (mmol g⁻¹ h⁻¹) and selectivity for products are strongly influenced by the reaction parameters. As the reaction time, catalyst amount, reaction temperature and molar ratios of NBS/toluene are increased, an increase in the conversion of NBS is noticed. Presumably, the catalytic bromination of aromatics proceeds by an electrophile (Br⁺) which is generated by the heterolytic cleavage of NBS/Br₂ by an acidic zeolite. Thus, the generated Br⁺ attacks the aromatic ring resulting in the formation of brominated nuclear products.     

Indirect Spectrofluorimetric Determination of Piroxicam and Propranolol Hydrochloride in Bulk and Pharmaceutical Preparations

A simple and sensitive indirect spectrofluorimetric method for the assay of piroxicam (PX) and propranolol hydrochloride (PPH) in the pure form and in pharmaceutical formulations is proposed. This method is based on the oxidation of PX and PPH by a known excess of N-bromosuccinimide (NBS) followed by the reaction of the excess NBS with methdilazine hydrochloride (MDH) to yield fluorescent species. The fluorescence intensities were measured at 377 nm after excitation at 343 nm. The fluorescence intensities decrease linearly with an increase in concentration of PX and PPH over the ranges of 0.2–8.0 and 0.4–18.0 g/mL respectively. The common excipients and additives did not interfere in the determination. The proposed method has been successfully applied for the determination of PX and PPH in pharmaceutical formulations. The results have been validated by statistical data.     

Spectrophotometric determination of drugs in pharmaceutical formulations withN-bromosuccinimide and celestine blue

Simple, sensitive and selective methods are proposed for the spectrophotometric determination of drugs, viz., tetracycline HCl, nifurtimox, ethionamide, propranolol HCl and isonicotinic acid hydrazide, based on their reactivity withN-bromosuccinimide (NBS). The method involves the addition of excess NBS of known concentration in the presence of 0.25M HCl and the unreacted NBS is determined by the measurement of the decrease in the absorbance of the dye celestine blue (_max 540 nm), which was found to be the most suitable of several dyes tested. This method was applied for the determination of drug contents in pharamaceutical formulations and enabled the determination of the drugs in microgram quantities (0.2 to 5 g/ml). Standard deviations were typically 0.5mg per dose (RSD 0.1–1.0%). No interferences were observed from excipients and the validity of the method was tested against reference method. Recoveries were 99.8–101.1%.